Long term efficacy and safety of beclomethasone dipropionate aerosol in Perennial Rhinitis.
Thirty-five patients with perennial rhinitis were treated with beclomethasone dipropionate nasal aerosol three times daily for 48 weeks. There was no evidence at the end of the study of any adverse effects from the topical steroid as assessed by biopsy studies of the nasal mucus membrane and by negative nasal cultures for C. albicans.
D000336:Aerosols; D001507:Beclomethasone / Q000008:administration & dosage* / Q000494:pharmacology; D001706:Biopsy; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009297:Nasal Mucosa / Q000187:drug effects / Q000473:pathology; D009666:Nose / Q000382:microbiology; D010919:Placebos; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*
D000336:Aerosols; D010919:Placebos; D001507:Beclomethasone